Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-12-02
1999-11-30
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530300, 530327, A61K 3800, A61K 3802, C07K 500, C07K 700
Patent
active
059943076
ABSTRACT:
This invention relates to the antibiotic feglymycin, as well as processes for its preparation and use. Feglymycin is represented by the structural formula (SEQ. ID. NO. 1) ##STR1##
REFERENCES:
Olivier Potterat et al., "Aborycin -a Tricyclic 21-Peptide Antibiotic Isolated from Streptomyces griseoflavus", Liebigs Ann. Chem. 1994, pp. 741-743.
Maki Nishio et al., "Siamycins I and II, New Anti-HIV Peptides" Journal of Antibiotics, 1995, vol. 48, No. 5, May 1995, pp. 433-434.
Aszodi Jozsef
Isert Dieter
Knauf Martin
Le Beller Dominique
Riess Gunther
Davenport Avis M.
Hoechst Aktiengesellschaft
LandOfFree
Methods of treatment with novel antibiotic feglymycin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treatment with novel antibiotic feglymycin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treatment with novel antibiotic feglymycin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1672634